期刊
LANCET NEUROLOGY
卷 21, 期 1, 页码 89-102出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S1474-4422(21)00330-6
关键词
-
资金
- UK National Institute for Health Research Biomedical Research Centre
- Maudsley NHS Foundation Trust
- King's College London
- University College London
- UK National Institute for Health Research, University College London Hospitals Biomedical Research Centre
Neuropsychiatric signs and symptoms are common in people with Parkinson's disease, and their underlying neurobiology is complex. Identifying risk factors and developing effective treatments require further research and specialized care models.
In people with Parkinson's disease, neuropsychiatric signs and symptoms are common throughout the disease course. These symptoms can be disabling and as clinically relevant as motor symptoms, and their presentation can be similar to, or distinct from, their counterparts in the general population. Correlates and risk factors for developing neuropsychiatric signs and symptoms include demographic, clinical, and psychosocial characteristics. The underlying neurobiology of these presentations is complex and not well understood, with the strongest evidence for neuropathological changes associated with Parkinson's disease, mechanisms linked to dopaminergic therapy, and effects not specific to Parkinson's disease. Assessment instruments and formal diagnostic criteria exist, but there is little routine screening of these signs and symptoms in clinical practice. Mounting evidence supports a range of pharmacological and non-pharmacological interventions, but relatively few efficacious treatment options exist. Optimising the management of neuropsychiatric presentations in people with Parkinson's disease will require additional research, raised awareness, specialised training, and development of innovative models of care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据